PL BioScience appoints Maik Jornitz to Board of Directors

pharmafile | June 24, 2026 | Appointment | Manufacturing and Production |  PL Bioscience 

PL BioScience has announced the appointment of Maik Jornitz to its board of directors, effective immediately. Jornitz brings technical expertise, strategic leadership and global industry influence to the board.

Jornitz, a subject matter expert in sterilising grade filtration, single-use bioprocesses and aseptic processing, is founder and principal consultant of BioProcess Resources, with a career spanning nearly four decades. He spent 26 years at Sartorius, where he rose to Senior Vice President for Global Product and Marketing Management Bioprocess, and ten years with G-CON Manufacturing, during which he built and successfully sold the company.

He is the former Board Chair of the Parenteral Drug Association (PDA), a global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. He currently serves on several additional boards and advisory bodies, including CleanSpace, DIANT Pharma, Sunflower Therapeutics and Bondwell.

Advertisement

PL BioScience is a German life science company specialising in the production and development of human platelet lysate (HPL) for cell expansion and manufacturing.

Related Content

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media

PL BioScience and DewCell Biotherapeutics have signed a Letter of Intent (LOI) for the development …

The Gateway to Local Adoption Series

Latest content